Antidiabetic properties of berberine: from cellular pharmacology to clinical effects. - Wikidata - awgldk - TriplyDB

Antidiabetic properties of berberine: from cellular pharmacology to clinical effects.

Antidiabetic properties of berberine: from cellular pharmacology to clinical effects.

http://www.wikidata.org/entity/Q38012073

about

A review of the effects of Berberis vulgaris and its major component, berberine, in metabolic syndrome In search of antiaging modalities: evaluation of mTOR- and ROS/DNA damage-signaling by cytometry.Berberine suppresses gero-conversion from cell cycle arrest to senescence.Potential anti-aging agents suppress the level of constitutive mTOR- and DNA damage- signaling O-hexadecyl-dextran entrapped berberine nanoparticles abrogate high glucose stress induced apoptosis in primary rat hepatocytes.Potential benefits of berberine in the management of perimenopausal syndrome.Berberis Vulgaris and Berberine: An Update Review.The metabolism of berberine and its contribution to the pharmacological effects.Effects of berberine on amelioration of hyperglycemia and oxidative stress in high glucose and high fat diet-induced diabetic hamsters in vivo.In Vitro Screening for Antihepatic Steatosis Active Components within Coptidis Rhizoma Alkaloids Extract Using Liver Cell Extraction with HPLC Analysis and a Free Fatty Acid-Induced Hepatic Steatosis HepG2 Cell Assay The Therapeutic Effect of Berberine in the Treatment of Nonalcoholic Fatty Liver Disease: A Meta-Analysis.GLP-I secretion in healthy and diabetic Wistar rats in response to aqueous extract of Momordica charantia.Berberine Ameliorates High Glucose-Induced Cardiomyocyte Injury via AMPK Signaling Activation to Stimulate Mitochondrial Biogenesis and Restore Autophagic Flux

P2860

Q33819610-4E13CB6E-C2CE-46FB-B8DD-AC6FC1D6A6F5 Q33841800-BAE3D36F-3DBA-44DA-822D-708370609A07 Q34366519-66F815B3-68AB-47A5-8A47-470A87378B93 Q34567724-4571CC02-6A64-4778-97A7-2D474A4E94BE Q35106703-8771BC95-3DE0-478E-B223-34F9DADC524B Q35138347-4645763D-8A20-4358-9927-68B37E3F1432 Q38928488-E69D874C-1842-4A26-BF94-67A626AD9DE7 Q39177350-E923381D-BEDB-45EB-B731-AE96F5B5D3C6 Q41841136-67697884-6FD9-48E8-AB8E-03558AD6B50A Q41846030-6F5788CB-6A15-4EE5-8A51-D2774DB89497 Q41974093-7668F795-CCE8-419A-94AB-2DF84E0E5152 Q55260061-4F710970-2A48-425E-8528-CA43F47C3FA8 Q58585321-F1E2497A-7BEE-4403-A21E-69F135E138E3

P2860

Antidiabetic properties of berberine: from cellular pharmacology to clinical effects.

http://www.wikidata.org/entity/Q38012073

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Antidiabetic properties of berberine: from cellular pharmacology to clinical effects.

@en

type

label

Antidiabetic properties of berberine: from cellular pharmacology to clinical effects.

@en

prefLabel

Antidiabetic properties of berberine: from cellular pharmacology to clinical effects.

@en

P1433

Q38012073-29833338-7D50-418D-89B0-097927F2B386

P1476

Q38012073-61A9DD08-4F1A-42AD-9C7F-455ACC0016A5

P2093

Q38012073-65527184-D32B-4C46-B394-AE91D5C65DBC

Q38012073-8986DEA9-7948-4F59-8308-3C9DFBB37354

P2860

Q38012073-00C052DD-865B-466E-B682-479CC9563D5C

Q38012073-083A9E70-92AC-4A7B-847E-67E6A685106F

Q38012073-08BA2C37-7D82-478D-A273-DB3E77B4BA5F

Q38012073-11780EA5-68BA-43E5-8F15-85CEC0AC03F5

Q38012073-184D34F4-886A-4B67-B00D-AF76574DAFCF

Q38012073-458ECE31-6CC4-4CBF-9847-D02AD760FE45

Q38012073-45DF5FE8-4425-493A-BD74-FB00AC0C26E8

Q38012073-46293E8A-350F-43AF-9E49-A4B0755BD344

Q38012073-4C65D2E9-2B9A-436B-A58B-AEE53D83D484

Q38012073-4EEF153A-26B3-47FC-AB4A-620ABF302F1B

P304

Q38012073-4F123BE0-8DAF-478F-9551-41AA7B914B2D

P31

Q38012073-0A2B12EC-CF98-4112-BB56-F57E0EEA9B7A

P356

Q38012073-0A6D508A-A5CF-4E04-81EE-46083770CE82

P407

Q38012073-394C8F88-B6CB-48FA-BFE4-85019139F791

P433

Q38012073-BC9FBF4A-6C31-4F12-81CC-C93E5ADE4F8E

P478

Q38012073-31FEFD29-0DF9-4032-AEB4-AC634FEBB57B

P577

Q38012073-D89D8E51-0C6B-4D35-84BA-78E265D06594

P5875

Q38012073-B4ED4CB1-74DB-4DE1-8431-5FB96D855CC1

P698

Q38012073-CC140CB5-ADAD-4074-9512-03D425EBED34

P921

Q38012073-0EAA2069-CAB0-4411-8A96-F7EDF5B3D97B

P356

P1433

Hospital Practice

P1476

Antidiabetic properties of berberine: from cellular pharmacology to clinical effects.

@en

P2093

Arrigo F G Cicero

http://www.w3.org/2001/XMLSchema#string

Elisa Tartagni

http://www.w3.org/2001/XMLSchema#string

P2860

Berberine improves glucose metabolism through induction of glycolysis

Efficacy of berberine in patients with type 2 diabetes mellitus

Facilitating effects of berberine on rat pancreatic islets through modulating hepatic nuclear factor 4 alpha expression and glucokinase activity

Traditional chinese medicine in treatment of metabolic syndrome

Effects and action mechanisms of berberine and Rhizoma coptidis on gut microbes and obesity in high-fat diet-fed C57BL/6J mice

Berberine improves glucose metabolism in diabetic rats by inhibition of hepatic gluconeogenesis

Chronic effects of berberine on blood, liver glucolipid metabolism and liver PPARs expression in diabetic hyperlipidemic rats

IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030

Protective effect of berberine on beta cells in streptozotocin- and high-carbohydrate/high-fat diet-induced diabetic rats.

Standards of medical care in diabetes--2010.

P304

56-63

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3810/HP.2012.04.970

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

40

http://www.w3.org/2001/XMLSchema#string

P577

2012-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

225054223

http://www.w3.org/2001/XMLSchema#string

P698

22615079

http://www.w3.org/2001/XMLSchema#string

P921